Clinical Trial Update: Genotype-guided Treatment in DLBCL [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating genotype-guided treatment for Diffuse Large B Cell Lymphoma (DLBCL) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 3 | Status: RECRUITING